Recrudescent Campylobacter jejuni infection in an immunocompetent adult following experimental infection with a well-characterized organism

Clinical and Vaccine Immunology

Volumn 17, Issue 1, 2010, Pages 80-86

  Baqar, Shahida ^a,b   Tribble, David R ^a,b   Carmolli, Marya ^c   Sadigh, Katrin ^c   Poly, Frederic ^a   Porter, Chad ^a   Larsson, Catherine J ^c   Pierce, Kristen K ^c   Guerry, Patricia ^a   Ventrone, Cassandra ^e   Dill, Elizabeth ^e   Daunais, Patrick ^e   Cummings, Garth ^e   Lyon, Caroline ^e   Fingar, Ann ^e   Gilliland Jr , Theron ^e   Jones, Erika ^e   Ewing, Cheryl P ^e   Dadouk, Sandra ^e   Sincock, Stephanie ^e   Lee, Lanfong ^e   Buchwaldt, Charlotte ^e   Puel, Pascale ^e   Miller, Robert ^e   Mattiesen, Dennis ^e   Darsley, Michael ^d   Kirkpatrick, Beth ^c   more..

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d ACE Biosciences   (Denmark)

^e UVM ^*  (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; C REACTIVE PROTEIN; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; GAMMA INTERFERON; IMIPENEM; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LEVOFLOXACIN; TETRACYCLINE;

ADAPTIVE IMMUNITY; ADD ON THERAPY; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BACKACHE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; CASE REPORT; CLINICAL EVALUATION; CONTROLLED STUDY; EXPERIMENTAL INFECTION; FATIGUE; FECES ANALYSIS; FECES CULTURE; FLUID RESUSCITATION; FOLLOW UP; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; IN VITRO STUDY; INFECTIOUS DIARRHEA; INNATE IMMUNITY; MALAISE; MALE; MULTIPLE CYCLE TREATMENT; MYALGIA; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RECURRENT INFECTION; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; ANTIGEN-PRESENTING CELLS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CYTOKINES; FECES; GASTROINTESTINAL TRACT; HUMANS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MALE; MICROBIAL SENSITIVITY TESTS; RECURRENCE; YOUNG ADULT;

EID: 74549184311     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00252-09     Document Type: Article

References (47)

1. Ahnen, D. J., and W. R. Brown. 1982. Campylobacter enteritis in immunedeficient patients. Ann. Intern. Med. 96:187-188.
2. Ajjampur, S. S., B. P. Gladstone, D. Selvapandian, J. P. Muliyil, H. Ward, and G. Kang. 2007. Molecular and spatial epidemiology of cryptosporidiosis in children in a semiurban community in South India. J. Clin. Microbiol. 45:915-920.
3. Allos, B. M. 1997. Association between Campylobacter infection and Guillain-Barre syndrome. J. Infect. Dis. 176(Suppl. 2):S125-S128.
4. Al-Salloom, F. S., A. Al Mahmeed, A. Ismaeel, G. A. Botta, and M. Bakhiet. 2003. Campylobacter-stimulated INT407 cells produce dissociated cytokine profiles. J. Infect. 47:217-224.
5. Anonymous. 2005. Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food - 10 sites, United States, 2004. MMWR Morb. Mortal. Wkly. Rep. 54:352-356.
6. Baqar, S., A. L. Bourgeois, P. J. Schultheiss, R. I. Walker, D. M. Rollins, R. L. Haberberger, and O. R. Pavlovskis. 1995. Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates. Vaccine 13:22-28.
7. Baqar, S., B. Rice, L. Lee, A. L. Bourgeois, A. N. El Din, D. R. Tribble, G. P. Heresi, A. S. Mourad, and J. R. Murphy. 2001. Campylobacter jejuni enteritis. Clin. Infect. Dis. 33:901-905.
8. Black, R. E., M. M. Levine, M. L. Clements, T. P. Hughes, and M. J. Blaser. 1988. Experimental Campylobacter jejuni infection in humans. J. Infect. Dis. 157:472-479.
9. Blaser, M. J., R. E. Black, D. J. Duncan, and J. Amer. 1985. Campylobacter jejuni-specific serum antibodies are elevated in healthy Bangladeshi children. J. Clin. Microbiol. 21:164-167.
10. Blaser, M. J., and D. J. Duncan. 1984. Human serum antibody response to Campylobacter jejuni infection as measured in an enzyme-linked immunosorbent assay. Infect. Immun. 44:292-298.
11. Blaser, M. J., W. J. Feldman, R. A. Pollard, and J. R. Allen. 1983. Campylobacter enteritis in the United States. A multicenter study. Ann. Intern. Med. 98:360-365.
12. Bourke, B., P. Sherman, H. Louie, E. Hani, P. Islur, and V. L. Chan. 1995. Physical and genetic map of the genome of Campylobacter upsaliensis. Microbiology 141(Pt 10):2417-2424.
13. Dworkin, B., G. P. Wormser, R. A. Abdoo, F. Cabello, M. E. Aguero, and S. L. Sivak. 1986. Persistence of multiply antibiotic-resistant Campylobacter jejuni in a patient with the acquired immune deficiency syndrome. Am. J. Med. 80:965-970.
14. Engberg, J., J. Neimann, E. M. Nielsen, F. M. Aerestrup, and V. Fussing. 2004. Quinolone-resistant Campylobacter infections: risk factors and clinical consequences. Emerg. Infect. Dis. 10:1056-1063.
15. Fields, J. A., and S. A. Thompson. 2008. Campylobacter jejuni CsrA mediates oxidative stress responses, biofilm formation, and host cell invasion. J. Bacteriol. 190:3411-3416.
16. Fouts, T. R., A. L. DeVico, D. Y. Onyabe, M. T. Shata, K. C. Bagley, G. K. Lewis, and D. M. Hone. 2003. Progress toward the development of a bacterial vaccine vector that induces high-titer long-lived broadly neutralizing antibodies against HIV-1. FEMS Immunol. Med. Microbiol. 37:129-134.
17. Gleeson, M. 2000. Special feature for the Olympics: effects of exercise on the immune system. Overview: exercise immunology. Immunol. Cell Biol. 78: 483-484.
18. Gleeson, M., and N. C. Bishop. 2000. Elite athlete immunology: importance of nutrition. Int. J. Sports Med. 21(Suppl. 1):S44-S50.
19. Gleeson, M., and D. B. Pyne. 2000. Special feature for the Olympics: effects of exercise on the immune system: exercise effects on mucosal immunity. Immunol. Cell Biol. 78:536-544.
20. Guerrant, R. L., T. Van Gilder, T. S. Steiner, N. M. Thielman, L. Slutsker, R. V. Tauxe, T. Hennessy, P. M. Griffin, H. DuPont, R. B. Sack, P. Tarr, M. Neill, I. Nachamkin, L. B. Reller, M. T. Osterholm, M. L. Bennish, and L. K. Pickering. 2001. Practice guidelines for the management of infectious diarrhea. Clin. Infect. Dis. 32:331-351.
21. Hammarstrom, V., C. I. Smith, and L. Hammarstrom. 1993. Oral immunoglobulin treatment in Campylobacter jejuni enteritis. Lancet 341:1036.
22. Hannu, T., L. Mattila, H. Rautelin, P. Pelkonen, P. Lahdenne, A. Siitonen, and M. Leirisalo-Repo. 2002. Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxford) 41:312-318.
23. Hu, L., and T. E. Hickey. 2005. Campylobacter jejuni induces secretion of proinflammatory chemokines from human intestinal epithelial cells. Infect. Immun. 73:4437-4440.
24. Janvier, B., S. Ayraud, A. Beby-Defaux, and J. Louis Fauchere. 2000. Immunogens of interest for the diagnosis of Campylobacter jejuni infections. FEMS Immunol. Med. Microbiol. 27:263-268.
25. Johnson, R. J., C. Nolan, S. P. Wang, W. R. Shelton, and M. J. Blaser. 1984. Persistent Campylobacter jejuni infection in an immunocompromised patient. Ann. Intern. Med. 100:832-834.
26. Kapperud, G., J. Lassen, S. M. Ostroff, and S. Aasen. 1992. Clinical features of sporadic Campylobacter infections in Norway. Scand. J. Infect. Dis. 24: 741-749.
27. Kerstens, P. J., H. P. Endtz, J. F. Meis, W. J. Oyen, R. J. Koopman, P. J. van den Broek, and J. W. van der Meer. 1992. Erysipelas-like skin lesions associated with Campylobacter jejuni septicemia in patients with hypogammaglobulinemia. Eur. J. Clin. Microbiol. Infect. Dis. 11:842-847.
28. Maslow, J. N., M. E. Mulligan, and R. D. Arbeit. 1993. Molecular epidemiology: application of contemporary techniques to the typing of microorganisms. Clin. Infect. Dis. 17:153-162.
29. Maslow, J. N., A. M. Slutsky, and R. D. Arbeit. 1993. The application of pulsed-field gel electrophoresis to molecular epidemiology, p. 563-572. In D. H. Persing, F. C. Tenover, T. F. Smith, and T. J. White (ed.), Diagnostic molecular microbiology. American Society for Microbiology, Washington, DC.
30. McKune, A. J., L. L. Smith, S. J. Semple, and A. A. Wadee. 2005. Influence of ultra-endurance exercise on immunoglobulin isotypes and subclasses. Br. J. Sports Med. 39:665-670.
31. Melamed, I., Y. Bujanover, Y. S. Igra, D. Schwartz, V. Zakuth, and Z. Spirer. 1983. Campylobacter enteritis in normal and immunodeficient children. Am. J. Dis. Child. 137:752-753.
32. Nachamkin, I., and A. M. Hart. 1985. Western blot analysis of the human antibody response to Campylobacter jejuni cellular antigens during gastrointestinal infection. J. Clin. Microbiol. 21:33-38.
33. Neill, M. A., S. M. Opal, J. Heelan, R. Giusti, J. E. Cassidy, R. White, and K. H. Mayer. 1991. Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis: experience during an outbreak in health care workers. Ann. Intern. Med. 114:195-199.
34. Pai, C. H., F. Gillis, E. Tuomanen, and M. I. Marks. 1983. Erythromycin in treatment of Campylobacter enteritis in children. Am. J. Dis. Child. 137: 286-288.
35. Perlman, D. M., N. M. Ampel, R. B. Schifman, D. L. Cohn, C. M. Patton, M. L. Aguirre, W. L. Wang, and M. J. Blaser. 1988. Persistent Campylobacter jejuni infections in patients infected with the human immunodeficiency virus (HIV). Ann. Intern. Med. 108:540-546.
36. Pichler, H., G. Diridl, and D. Wolf. 1986. Ciprofloxacin in the treatment of acute bacterial diarrhea: a double blind study. Eur. J. Clin. Microbiol. 5:241-243.
37. Poly, F., C. Ewing, S. Goon, T. E. Hickey, D. Rockabrand, G. Majam, L. Lee, J. Phan, N. J. Savarino, and P. Guerry. 2007. Heterogeneity of a Campylobacter jejuni protein that is secreted through the flagellar filament. Infect. Immun. 75:3859-3867.
38. Poly, F., T. D. Read, Y. H. Chen, M. A. Monteiro, O. Serichantalergs, P. Pootong, L. Bodhidatta, C. J. Mason, D. Rockabrand, S. Baqar, C. K. Porter, D. Tribble, M. Darsley, and P. Guerry. 2008. Characterization of two Campylobacter jejuni strains for use in volunteer experimental infection studies. Infect. Immun. 76:5655-5667.
39. Ruiz-Palacios, G. M. 2007. The health burden of Campylobacter infection and the impact of antimicrobial resistance: playing chicken. Clin. Infect. Dis. 44:701-703.
40. Strid, M. A., J. Engberg, L. B. Larsen, K. Begtrup, K. Molbak, and K. A. Krogfelt. 2001. Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients. Clin. Diagn. Lab. Immunol. 8:314-319.
41. Taylor, B. V., J. Williamson, D. Jones, D. Coleman, J. Luck, and A. McGregor. 2007. Utility of serum Campylobacter specific antibodies in determining prior Campylobacter infection in neurological disease. J. Clin. Neurosci. 14:116-121.
42. Ternhag, A., T. Asikainen, J. Giesecke, and K. Ekdahl. 2007. A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species. Clin. Infect. Dis. 44:696-700.
43. Thornley, J. P., D. Jenkins, K. Neal, T. Wright, J. Brough, and R. C. Spiller. 2001. Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome. J. Infect. Dis. 184:606-609.
44. Tribble, D., S. Baqar, M. P. Carmolli, C. K. Porter, K. K. Pierce, S. K. Sadigh, P. Guerry, C. Larsson, D. Rockabrand, C. Ventrone, F. Poly, C. E. Lyon, S. Dakdouk, A. Fingar, T. C. Gilliland, Jr., P. Daunais, E. Jones, S. L. Rymarchyk, C. D. Huston, M. Darsley, and B. D. Kirkpatrick. 2009. Campylobacter jejuni strain CG8421: a refined model for the study of campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clin. Infect. Dis. 49:1512-1519.
45. Tribble, D. R., J. W. Sanders, L. W. Pang, C. Mason, C. Pitarangsi, S. Baqar, A. Armstrong, P. Hshieh, A. Fox, E. A. Maley, C. Lebron, D. J. Faix, J. V. Lawler, G. Nayak, M. Lewis, L. Bodhidatta, and D. A. Scott. 2007. Traveler's diarrhea in Thailand: randomized, double-blind trial comparing single-dose and 3-day azithromycin-based regimens with a 3-day levofloxacin regimen. Clin. Infect. Dis. 44:338-346.
46. Walz, S., S. Baqar, H. Beecham, et al. 2001. Pre-exposure anti-Campylobacter jejuni immunoglobulin a levels associated with reduced risk of Campylobacter diarrhea in adults traveling to Thailand. Am. J. Trop. Med. Hyg. 65:652-656.
47. Zilbauer, M., N. Dorrell, P. K. Boughan, A. Harris, B. W. Wren, N. J. Klein, and M. Bajaj-Elliott. 2005. Intestinal innate immunity to Campylobacter jejuni results in induction of bactericidal human beta-defensins 2 and 3. Infect. Immun. 73:7281-7289.